Second-look surgery in postoperative pediatric low-grade glioma.
Low-grade glioma
Neurodeficit
Second-look surgery
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
06 Jul 2024
06 Jul 2024
Historique:
received:
10
04
2024
accepted:
20
06
2024
medline:
6
7
2024
pubmed:
6
7
2024
entrez:
6
7
2024
Statut:
aheadofprint
Résumé
To review the literature on second-look surgery in pediatric low-grade gliomas (LGG) with a view to presenting both sides of the picture of re-exploration. Collection of material from recent literature on pediatric LGG. This was a retrospective review of these publications. There are a number of publications recommending second-look surgery in selected cases, provided morbidity of the second surgery is minimum, and indeed some in which there is improvement in the neurodeficit after the second resection. There seems a fair balance of articles recommending and dissuading the practice of second-look surgery, but in our limited experience we have found it useful in selected patients.
Identifiants
pubmed: 38970692
doi: 10.1007/s00381-024-06516-3
pii: 10.1007/s00381-024-06516-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-Oncol. 22(Suppl 1):iv1-96
pubmed: 33123732
pmcid: 7596247
doi: 10.1093/neuonc/noaa200
Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL et al (2015) Alex’s Lemonade Stand Foundation Infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-Oncol. 16(Suppl 10 Suppl 10):x1-36
pubmed: 25542864
doi: 10.1093/neuonc/nou327
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncol 20(suppl_4):1–86
doi: 10.1093/neuonc/noy131
Rickert CH, Paulus W (2001) Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 17(9):503–511
doi: 10.1007/s003810100496
Sievert AJ, Fisher MJ (2009) Pediatric low-grade gliomas. J Child Neurol 24(11):1397–1408
pubmed: 19841428
pmcid: 2917804
doi: 10.1177/0883073809342005
Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ et al (2014) Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61(7):1173–9
pubmed: 24482038
pmcid: 4657506
doi: 10.1002/pbc.24958
Ryall S, Tabori U, Hawkins C (2020) Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 8(1):30
pubmed: 32164789
pmcid: 7066826
doi: 10.1186/s40478-020-00902-z
Wefers AK, Stichel D, Schrimpf D, Coras R, Pages M, Tauziède-Espariat A et al (2020) Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathol (Berl) 139(1):193–209
pubmed: 31563982
doi: 10.1007/s00401-019-02078-w
Ellison DW, Hawkins C, Jones DTW, Onar-Thomas A, Pfister SM, Reifenberger G et al (2019) cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation. Acta Neuropathol (Berl) 137(4):683–687
pubmed: 30848347
doi: 10.1007/s00401-019-01987-0
Johnson DR, Giannini C, Jenkins RB, Kim DK, Kaufmann TJ (2019) Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young. Neuroradiology 61(11):1327–1332
pubmed: 31396664
doi: 10.1007/s00234-019-02269-y
Huse JT, Snuderl M, Jones DTW, Brathwaite CD, Altman N, Lavi E et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol (Berl) 133(3):417–429
pubmed: 27812792
doi: 10.1007/s00401-016-1639-9
Surrey LF, Jain P, Zhang B, Straka J, Zhao X, Harding BN et al (2019) Genomic analysis of dysembryoplastic neuroepithelial tumor spectrum reveals a diversity of molecular alterations dysregulating the MAPK and PI3K/mTOR pathways. J Neuropathol Exp Neurol 78(12):1100–1111
pubmed: 31617914
doi: 10.1093/jnen/nlz101
Bitar M, Danish SF, Rosenblum MK (2018) A newly diagnosed case of polymorphous low-grade neuroepithelial tumor of the young. Clin Neuropathol 37(4):178–181
pubmed: 29701169
pmcid: 6657424
doi: 10.5414/NP301081
Gupta VR, Giller C, Kolhe R, Forseen SE, Sharma S (2019) Polymorphous low-grade neuroepithelial tumor of the young: a case report with genomic findings. World Neurosurg 132:347–355
pubmed: 31520766
doi: 10.1016/j.wneu.2019.08.221
Bale TA, Sait SF, Benhamida J, Ptashkin R, Haque S, Villafania L et al (2021) Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY). Acta Neuropathol (Berl) 141(1):123–125
pubmed: 33226472
doi: 10.1007/s00401-020-02245-4
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncol 23(8):1231–1251
pubmed: 34185076
pmcid: 8328013
doi: 10.1093/neuonc/noab106
Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol (Berl) 136(2):181–210
pubmed: 29967940
doi: 10.1007/s00401-018-1879-y
Pickles JC, Mankad K, Aizpurua M, Paine SM, Bridges LR, Carceller F et al (2021) A case series of diffuse glioneuronal tumours with oligodendroglioma-like features and nuclear clusters (DGONC). Neuropathol Appl Neurobiol 47(3):464–467
pubmed: 33325069
pmcid: 8048648
doi: 10.1111/nan.12680
Lucas CHG, Villanueva-Meyer JE, Whipple N, Oberheim Bush NA, Cooney T, Chang S et al (2020) Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathol Zurich Switz 30(3):479–94
doi: 10.1111/bpa.12797
Cervera-Pierot P, Varlet P, Chodkiewicz JP, Daumas-Duport C (1997) Dysembryoplastic neuroepithelial tumors located in the caudate nucleus area: report of four cases. Neurosurgery 40(5):1065–9 (discussion 1069-1070)
pubmed: 9149266
doi: 10.1097/00006123-199705000-00035
Chiang JCH, Harreld JH, Tanaka R, Li X, Wen J, Zhang C et al (2019) Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis. Neuro-Oncol 21(6):800–808
pubmed: 30726976
pmcid: 6556860
doi: 10.1093/neuonc/noz037
Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ et al (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncol 12(12):1257–1268
pubmed: 20861086
pmcid: 3018938
Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-Oncol 14(10):1265–1284
pubmed: 22942186
pmcid: 3452343
doi: 10.1093/neuonc/nos202
Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ et al (2011) Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery 68(6):1548–54 (discussion 1554-1555)
pubmed: 21368693
doi: 10.1227/NEU.0b013e318214a66e
Hayostek CJ, Shaw EG, Scheithauer B, O’Fallon JR, Weiland TL, Schomberg PJ et al (1993) Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 72(3):856–69
pubmed: 8334640
doi: 10.1002/1097-0142(19930801)72:3<856::AID-CNCR2820720335>3.0.CO;2-K
Steinbok P, Hentschel S, Cochrane DD, Kestle JR (1996) Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84(5):726–732
pubmed: 8622143
doi: 10.3171/jns.1996.84.5.0726
Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro-Oncol 5(3):153–160
pubmed: 12816721
pmcid: 1920689
doi: 10.1215/S1152851702000601
Rozen WM, Joseph S, Lo PA (2008) Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis. Pediatr Neurosurg 44(4):324–328
pubmed: 18504420
doi: 10.1159/000134925
Schmandt SM, Packer RJ, Vezina LG, Jane J (2000) Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 32(3):132–136
pubmed: 10867559
doi: 10.1159/000028917
Abdollahzadeh M, Hoffman HJ, Blazer SI, Becker LE, Humphreys RP, Drake JM et al (1994) Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980–1992. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 10(6):380–383
doi: 10.1007/BF00335126
Benesch M, Eder HG, Sovinz P, Raith J, Lackner H, Moser A et al (2006) Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003. Pediatr Neurosurg 42(3):159–164
pubmed: 16636617
doi: 10.1159/000091859
Garcia DM, Marks JE, Latifi HR, Kliefoth AB (1990) Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? Int J Radiat Oncol Biol Phys 18(4):815–818
pubmed: 2323970
doi: 10.1016/0360-3016(90)90402-6
Khajavi K, Comair YG, Wyllie E, Palmer J, Morris HH, Hahn JF (1999) Surgical management of pediatric tumor-associated epilepsy. J Child Neurol 14(1):15–25
pubmed: 10025536
doi: 10.1177/088307389901400102
Krieger MD, Gonzalez-Gomez I, Levy ML, McComb JG (1997) Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 27(1):1–11
pubmed: 9486830
doi: 10.1159/000121218
Luyken C, Blümcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD et al (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44(6):822–830
pubmed: 12790896
doi: 10.1046/j.1528-1157.2003.56102.x
Nolan MA, Sakuta R, Chuang N, Otsubo H, Rutka JT, Snead OC et al (2004) Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology 62(12):2270–2276
pubmed: 15210893
doi: 10.1212/01.WNL.0000130495.69512.6F
Ogiwara H, Bowman RM, Tomita T (2012) Long-term follow-up of pediatric benign cerebellar astrocytomas. Neurosurgery 70(1):40–7 (discussion 47-48)
pubmed: 21808215
doi: 10.1227/NEU.0b013e31822ff0ed
Saunders DE, Phipps KP, Wade AM, Hayward RD (2005) Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma. J Neurosurg 102(2 Suppl):172–178
pubmed: 16156227
doi: 10.3171/jns.2005.102.2.0172
Sutton LN, Cnaan A, Klatt L, Zhao H, Zimmerman R, Needle M et al (1996) Postoperative surveillance imaging in children with cerebellar astrocytomas. J Neurosurg 84(5):721–725
pubmed: 8622142
doi: 10.3171/jns.1996.84.5.0721
Vassilyadi M, Shamji MF, Tataryn Z, Keene D, Ventureyra E (2009) Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. Can J Neurol Sci J Can Sci Neurol 36(6):707–712
doi: 10.1017/S0317167100008313
Dorward IG, Luo J, Perry A, Gutmann DH, Mansur DB, Rubin JB et al (2010) Postoperative imaging surveillance in pediatric pilocytic astrocytomas. J Neurosurg Pediatr 6(4):346–352
pubmed: 20887107
doi: 10.3171/2010.7.PEDS10129
Kim AH, Thompson EA, Governale LS, Santa C, Cahll K, Kieran MW et al (2014) Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging. J Neurosurg Pediatr 14(4):356–364
pubmed: 25062303
pmcid: 4858166
doi: 10.3171/2014.6.PEDS1321
Due-Tønnessen BJ, Helseth E, Scheie D, Skullerud K, Aamodt G, Lundar T (2002) Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0–19 years): report of 110 consecutive cases. Pediatr Neurosurg 37(2):71–80
pubmed: 12145515
doi: 10.1159/000065108
Zaazoue MA, Manley PE, Mehdar MA, Ullrich NJ, Dasenbrock HH, Chordas CA et al (2020) Optimizing postoperative surveillance of pediatric low-grade glioma using tumor behavior patterns. Neurosurgery 86(2):288–297
pubmed: 30892635
doi: 10.1093/neuros/nyz072
Kramer ED, Vezina LG, Packer RJ, Fitz CR, Zimmerman RA, Cohen MD (1994) Staging and surveillance of children with central nervous system neoplasms: recommendations of the Neurology and Tumor Imaging Committees of the Children’s Cancer Group. Pediatr Neurosurg. 20(4):254–62 (discussion 262-263)
pubmed: 8043464
doi: 10.1159/000120799
Roder C, Breitkopf M, Null Ms, Bisdas S, da Freitas SR, Dimostheni A et al (2016) Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery. Neurosurg Focus 40(3):E13
pubmed: 26926053
doi: 10.3171/2015.11.FOCUS15530
Lorenzen A, Groeschel S, Ernemann U, Wilke M, Schuhmann MU (2018) Role of presurgical functional MRI and diffusion MR tractography in pediatric low-grade brain tumor surgery: a single-center study. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 34(11):2241–2248
doi: 10.1007/s00381-018-3828-4
Carai A, De Benedictis A, Calloni T, Onorini N, Paternò G, Randi F et al (2021) Intraoperative ultrasound-assisted extent of resection assessment in pediatric neurosurgical oncology. Front Oncol 11:660805
pubmed: 33968768
pmcid: 8097032
doi: 10.3389/fonc.2021.660805
Gorodezki D, Zipfel J, Queudeville M, Sosa J, Holzer U, Kern J et al (2022) Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis. J Neurooncol 160(3):567–576
pubmed: 36319795
pmcid: 9758245
doi: 10.1007/s11060-022-04176-4
Krishnatry R, Zhukova N, Guerreiro Stucklin AS, Pole JD, Mistry M, Fried I et al (2016) Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: a population-based study. Cancer 122(8):1261–1269
pubmed: 26970559
doi: 10.1002/cncr.29907
Nageswara Rao AA, Packer RJ (2014) Advances in the management of low-grade gliomas. Curr Oncol Rep 16(8):398
pubmed: 24925153
doi: 10.1007/s11912-014-0398-9
Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R et al (2017) Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol Off J Am Soc Clin Oncol 35(25):2934–2941
doi: 10.1200/JCO.2016.71.8726
Mistry M, Zhukova N, Merico D, Rakopoulos P, Krishnatry R, Shago M et al (2015) BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol Off J Am Soc Clin Oncol 33(9):1015–1022
doi: 10.1200/JCO.2014.58.3922
Lawson ARJ, Tatevossian RG, Phipps KP, Picker SR, Michalski A, Sheer D et al (2010) RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort. Acta Neuropathol (Berl) 120(2):271–273
pubmed: 20454969
doi: 10.1007/s00401-010-0693-y
Faulkner C, Ellis HP, Shaw A, Penman C, Palmer A, Wragg C et al (2015) BRAF fusion analysis in pilocytic astrocytomas: KIAA1549-BRAF 15–9 fusions are more frequent in the midline than within the cerebellum. J Neuropathol Exp Neurol 74(9):867–872
pubmed: 26222501
doi: 10.1097/NEN.0000000000000226
Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T et al (2017) A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro-Oncol 19(8):1135–1144
pubmed: 28339824
pmcid: 5570236
doi: 10.1093/neuonc/now282
Lassaletta A, Guerreiro Stucklin A, Ramaswamy V, Zapotocky M, McKeown T, Hawkins C et al (2016) Profound clinical and radiological response to BRAF inhibition in a 2-month-old diencephalic child with hypothalamic/chiasmatic glioma. Pediatr Blood Cancer 63(11):2038–2041
pubmed: 27398937
doi: 10.1002/pbc.26086
Bavle A, Jones J, Lin FY, Malphrus A, Adesina A, Su J (2017) Dramatic clinical and radiographic response to BRAF inhibition in a patient with progressive disseminated optic pathway glioma refractory to MEK inhibition. Pediatr Hematol Oncol 34(4):254–259
pubmed: 29040023
doi: 10.1080/08880018.2017.1360971
del Bufalo F, Carai A, Figà-Talamanca L, Pettorini B, Mallucci C, Giangaspero F et al (2014) Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent. J Transl Med 19(12):356
doi: 10.1186/s12967-014-0356-1
van Tilburg CM, Selt F, Sahm F, Bächli H, Pfister SM, Witt O et al (2018) Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib. Pediatr Blood Cancer 65(3):e26893. https://doi.org/10.1002/pbc.26893
Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 30(21):2641–2647
doi: 10.1200/JCO.2011.36.6054
Lassaletta A, Scheinemann K, Zelcer SM, Hukin J, Wilson BA, Jabado N et al (2016) Phase II weekly vinblastine for chemotherapy-naïve children with progressive low-grade glioma: a Canadian Pediatric Brain Tumor Consortium Study. J Clin Oncol Off J Am Soc Clin Oncol 34(29):3537–3543
doi: 10.1200/JCO.2016.68.1585
de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J (2019) Management of pediatric low-grade glioma. Curr Opin Pediatr 31(1):21–27
pubmed: 30531227
pmcid: 6664811
doi: 10.1097/MOP.0000000000000717
Dodgshun AJ, Maixner WJ, Hansford JR, Sullivan MJ (2016) Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging. J Neurosurg Pediatr 17(5):569–572
pubmed: 26722760
doi: 10.3171/2015.9.PEDS15449
Hwang EI, Jakacki RI, Fisher MJ, Kilburn LB, Horn M, Vezina G et al (2013) Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatr Blood Cancer 60(5):776–782
pubmed: 22976922
doi: 10.1002/pbc.24297
Chintagumpala M, Eckel SP, Krailo M, Morris M, Adesina A, Packer R et al (2015) A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children’s Oncology Group study†. Neuro-Oncol 17(8):1132–1138
pubmed: 25854526
pmcid: 4490875
doi: 10.1093/neuonc/nov057
Dirven CM, Mooij JJ, Molenaar WM (1997) Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 13(1):17–23
doi: 10.1007/s003810050033
Schneider JH, Raffel C, McComb JG (1992) Benign cerebellar astrocytomas of childhood. Neurosurgery 30(1):58–6
pubmed: 1738456
doi: 10.1227/00006123-199201000-00011
Smoots DW, Geyer JR, Lieberman DM, Berger MS (1998) Predicting disease progression in childhood cerebellar astrocytoma. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 14(11):636–648
doi: 10.1007/s003810050290
Gruszka E (1970) Morphologic anaplasia in cerebellar gliomas with long survival time. Folia Med Cracov 12(1):127–144
pubmed: 5425920
Campbell JW, Pollack IF (1996) Cerebellar astrocytomas in children. J Neurooncol 28(2–3):223–231
pubmed: 8832464
Pencalet P, Maixner W, Sainte-Rose C, Lellouch-Tubiana A, Cinalli G, Zerah M et al (1999) Benign cerebellar astrocytomas in children. J Neurosurg 90(2):265–273
pubmed: 9950497
doi: 10.3171/jns.1999.90.2.0265
Palma L, Celli P, Mariottini A (2004) Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumour regression. Acta Neurochir (Wien) 146(6):581–8 (discussion 588)
pubmed: 15168226
doi: 10.1007/s00701-004-0257-9
Budka H (1975) Partially resected and irradiated cerebellar astrocytoma of childhood: malignant evolution after 28 years. Acta Neurochir (Wien) 32(1–2):139–146
pubmed: 1163315
doi: 10.1007/BF01405911
Kleinman GM, Schoene WC, Walshe TM, Richardson EP (1978) Malignant transformation in benign cerebellar astrocytoma. Case report J Neurosurg 49(1):111–118
pubmed: 660255
Pagni CA, Giordana MT, Canavero S (1991) Benign recurrence of a pilocytic cerebellar astrocytoma 36 years after radical removal: case report. Neurosurgery 28(4):606–609
pubmed: 2034360
doi: 10.1227/00006123-199104000-00023
Scott RM, Ballantine HT (1973) Cerebellar astrocytoma: malignant recurrence after prolonged postoperative survival. Case report J Neurosurg 39(6):777–779
pubmed: 4759666
Yoshizumi MO (1979) Neuro-ophthalmologic signs in a recurrent cerebellar astrocytoma after 48 years. Ann Ophthalmol 11(11):1714–1719
pubmed: 556130
Bowers DC, Krause TP, Aronson LJ, Barzi A, Burger PC, Carson BS et al (2001) Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg 34(5):229–234
pubmed: 11423771
doi: 10.1159/000056027
Wisoff JH, Abbott R, Epstein F (1990) Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73(5):661–667
pubmed: 2213155
doi: 10.3171/jns.1990.73.5.0661
Diwanji TP, Engelman A, Snider JW, Mohindra P (2017) Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults. Adolesc Health Med Ther 8:99–113
pubmed: 28989289
pmcid: 5624597
Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S et al (2016) Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol 17(4):484–495
pubmed: 26976201
pmcid: 4907853
doi: 10.1016/S1470-2045(15)00581-1
Pajtler KW, Mack SC, Ramaswamy V, Smith CA, Witt H, Smith A et al (2017) The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol (Berl) 133(1):5–12
pubmed: 27858204
doi: 10.1007/s00401-016-1643-0
Massimino M, Solero CL, Garrè ML, Biassoni V, Cama A, Genitori L et al (2011) Second-look surgery for ependymoma: the Italian experience. J Neurosurg Pediatr 8(3):246–250
pubmed: 21882914
doi: 10.3171/2011.6.PEDS1142
Millward CP, Mallucci C, Jaspan T, Macarthur D, Heyward R, Cox T et al (2016) Assessing “second-look” tumour resectability in childhood posterior fossa ependymoma-a centralised review panel and staging tool for future studies. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 32(11):2189–2196
doi: 10.1007/s00381-016-3225-9
Beez T, Sarikaya-Seiwert S, Steiger HJ, Hänggi D (2014) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children–a technical report. Acta Neurochir (Wien) 156(3):597–604
pubmed: 24449149
doi: 10.1007/s00701-014-1997-9
Patel V, McNinch NL, Rush S (2019) Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience. J Neurooncol 143(2):297–304
pubmed: 30929127
doi: 10.1007/s11060-019-03160-9
Schmidt MH, Berger MS, Lamborn KR, Aldape K, McDermott MW, Prados MD et al (2003) Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg 98(6):1165–1169
pubmed: 12816258
doi: 10.3171/jns.2003.98.6.1165
Martino J, Taillandier L, Moritz-Gasser S, Gatignol P, Duffau H (2009) Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas. Acta Neurochir (Wien) 151(5):427–436
pubmed: 19337688
doi: 10.1007/s00701-009-0232-6